ArticleBMC biotechnology2025
Improvements of gamma radiation-induced immunological, hematological, and some biochemical changes in male albino rats by custard apple (Annona squamosa) seed oil extract.
Article in BMC biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnnona squamosa seed oil extract (ASSOE) was used in the current study to investigate the radioprotective potential of ASSOE on radiation-induced hematological, immunological, and biochemical parameters in albino male rats. MATERIALS AND
methodsThe fatty acid profile of ASSOE was analyzed using GC. Total phenolic content (TPC) and total flavonoid content (TFC) were determined. Antioxidant activity for ASSOE was assayed by the DPPH activity assay, the anticancer activity was also valuated. Forty-nine male albino rats were separated into seven groups: group 1 (normal rats) were administered saline by gavage. Rats in the 2nd, 3rd , and 4th groups were subjected to a single dose of γ-radiation (4, 6, and 8 Gy), respectively, and then administered saline by gavage. The 5th, 6th, and 7th groups of rats were subjected to gamma radiation with 4, 6, and 8 Gy, respectively, then administered ASSOE by gavage (200 mg/kg B.W.) for 14 consecutive days.
resultsAnnona squamosa seed oil yield was 28.13%, which gave a TPC of 0.71 mg/g ASSOE, TFC of 0.145 mg/g ASSOE and DPPH percentage (65.41%). Fatty acids in ASSOE were oleic acid (57.80%), linoleic acid (23.31%), and palmitic acid (16.22%). The anticancer impact of ASSOE against Caco-2 and HepG-2 cell lines were, 47 ± 0.68 and 912.33 ± 10.81 µg/ml), respectively. Treated rats with ASSOE showed a noticeable increase in the percentage of immune cells, including CD4 and CD8. C-Reactive Protein (CRP) and Tumor Necrosis Factor-α (TNF-α) levels increased following γ-irradiation, but they dramatically dropped after 14 days of administration of ASSOE. Moreover, the 5th, 6th, and 7th groups exhibited notable improvements in all hematological parameters. After 14 days of treatment with ASSOE, cholesterol and triglyceride levels significantly decreased, reversing the rise that occurred following γ-irradiation.
conclusionASSOE is an excellent immunomodulator, radioprotector, and biochemical enhancer, suggesting that it might be used as an adjuvant during radiation therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.